SCHEMBL6891679

SCHEMBL6891679

CN(CCOC1SC(=O)NC1=O)c1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 11/20 0.64
RARG P13631 1/20 0.56
RXRA P19793 1/20 0.56
MAPT P10636 5/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 2/20 0.49
PKM P14618 2/20 0.49
HTT P42858 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.46
KMT2A Q03164 3/20 0.46
PPARA Q07869 2/20 0.38
MEN1 O00255 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CYP2C19 P33261 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
GMNN O75496 1/20 0.38
EGFR P00533 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Rosiglitazone SCHEMBL29530259 0.78 PPARG (1.00) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL11957687 0.78 PPARG (1.00) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL7052472 0.78 PPARG (1.00) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL2355017 0.78 PPARG (1.00) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL5169 0.78 PPARG (1.00) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL3377103 0.77 PPARG (0.98) PPARGRARGRXRAMAPTALDH1A1
SCHEMBL6258222 0.77 PPARG (0.56) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL1489117 0.77 PPARG (0.98) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL5468691 0.77 PPARG (0.98) PPARGRARGRXRAMAPTALDH1A1
Rosiglitazone SCHEMBL3375739 0.77 PPARG (0.98) PPARGRARGRXRAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173437-B1 THIAZOLIDINEDIONE DERIVATIVE AND ITS USE AS ANTIDIABETIC SMITHKLINE BEECHAM PLC (GB) 2004-03-24 EP disclosed
US-20040034066-A1 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]thiazolidine-2,4-dione SMITHKLINE BEECHAM P.L.C. (GB) 2004-02-19 US disclosed
EP-1332142-A1 SODIUM SALTS OF 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]B ENZYL]THIAZOLIDINE-2,4-DIONE SmithKline Beecham p.l.c. (GB) 2003-08-06 EP disclosed
WO-2002026735-A1 SODIUM SALTS OF 5-'4-'2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINE-2,4-DIONE SMITHKLINE BEECHAM P.L.C. (GB) 2002-04-04 WO disclosed